|
|
Airsculpt Technologies Inc (NASDAQ: AIRS) |
|
Price: $1.9600
$0.14 
7.692%
|
| Day's High:
| $1.96
| Week Perf:
| 18.43 %
|
| Day's Low: |
$ 1.77 |
30 Day Perf: |
-28.47 % |
| Volume (M): |
124 |
52 Wk High: |
$ 9.20 |
| Volume (M$): |
$ 242 |
52 Wk Avg: |
$4.66 |
| Open: |
$1.79 |
52 Wk Low: |
$1.53 |
|
|
| Market Capitalization (Millions $) |
116 |
| Shares
Outstanding (Millions) |
59 |
| Employees |
31 |
| Revenues (TTM) (Millions $) |
180 |
| Net Income (TTM) (Millions $) |
-8 |
| Cash Flow (TTM) (Millions $) |
-2 |
| Capital Exp. (TTM) (Millions $) |
14 |
Airsculpt Technologies Inc
Airsculpt Technologies Inc is a medical technology company that specializes in non-invasive and minimally invasive fat removal procedures.
The company was founded in 2015 by Dr.
Aaron Rollins, who is a renowned plastic surgeon and expert in body contouring techniques.
The company's signature procedure is called AirSculpt, which uses patented technology and techniques to remove fat cells from the body.
AirSculpt is a minimally invasive procedure that uses a small cannula to remove fat cells, without the need for general anesthesia or major incisions.
The process involves injecting a specially formulated solution into the treatment area, which then emulsifies the fat cells and makes them easier to remove.
The cannula is then inserted into the treatment area, and the fat cells are suctioned out of the body.
Airsculpt Technologies Inc has developed a variety of different AirSculpt procedures, each of which is specifically designed to address different areas of the body.
These include treatments for the arms, thighs, buttocks, abdomen, and other areas.
The company's technology is based on a series of patents that Dr.
Rollins has developed, which cover everything from the design of the cannula to the formulation of the solution that is used.
Airsculpt Technologies Inc is also committed to using sustainable materials and reducing waste in its procedures.
The company uses reusable cannulas and recyclable packaging materials, as well as minimizing the use of single-use plastics.
In addition to its focus on fat removal procedures, Airsculpt Technologies Inc is also involved in research and development of other medical technologies related to body and facial contouring.
Overall, Airsculpt Technologies Inc is a cutting-edge medical technology company that is focused on providing innovative, minimally invasive solutions to body contouring and fat removal.
Its AirSculpt procedures are gaining popularity and becoming an increasingly popular option for people looking to achieve their ideal body shape.
Company Address: 1111 Lincoln Road Miami Beach 33139 FL
Company Phone Number: 709-9690 Stock Exchange / Ticker: NASDAQ AIRS
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Management Announcement
Published Mon, Jan 13 2025 11:45 AM UTC
By Miami Beach, Fla. ? AirSculpt Technologies, Inc. (NASDAQ: AIRS) is implementing strategic changes and updating projections for fiscal year 2024, yet the company s recent performance metrics signal a tougher road ahead. With the company gearing up to present at the ICR Conference 2025, questions linger about its capacity to regain traction in an increasingly competitive la...
|
| Management Changes
Published Tue, Dec 17 2024 11:45 AM UTC
In a significant move that underscores its commitment to innovation and excellence in the field of body contouring, AirSculpt Technologies, Inc. (NASDAQ:AIRS) has announced the appointment of Yogi Jashnani as the new Chief Executive Officer (CEO) and a member of the Board of Directors. This strategic leadership transition is set to take effect on January 7, 2025, with Yogi s...
|
| Airsculpt Technologies Inc
AirSculpt Technologies Inc, a national provider of premium body contouring procedures, recently reported its financial results for the first quarter ended March 31, 2024. The company's income per share remained steady at $0.10 per share compared to $0.00 a year prior, and income per share turned positive from $-0.08 per share from the previous reporting season. This improvement in earnings per share is a positive sign for the company.
In terms of revenue, AirSculpt Technologies Inc saw a moderate increase of 3.944% to $47.62 million from $45.81 million in the similar reporting season a year prior. While the revenue growth is positive, it fell short of the Healthcare Facilities sector's overall growth rate of 10.02% relative to Q1 of 2023. However, the company reported net earnings of $6.029 million in the most recent fiscal period, a significant improvement from a net loss of $-0.014 million in the same reporting season a year ago.
|
| Airsculpt Technologies Inc
Airsculpt Technologies Inc Reports Increase in Revenue but a Higher Loss per Share in Q4 2023
Miami Beach, FL ? AirSculpt Technologies, Inc. (NASDAQ:AIRS), a leading provider of premium body contouring procedures, announced its financial results for the fourth quarter and full year ended December 31, 2023. The company experienced an increase in revenue during the fourth quarter, but also reported a higher loss per share compared to the previous year.
In the fourth quarter of 2023, Airsculpt Technologies Inc reported a loss per share of $-0.08, which was an increase from $0.00 in the same quarter a year before. Additionally, the company's loss per share surged from $-0.03 in the preceding quarter. Despite this, the revenue grew by a respectable 16.961%, reaching $47.61 million compared to $40.70 million in the corresponding quarter a year before. Sequentially, the revenue increased by 1.742% from $46.79 million.
|
| Airsculpt Technologies Inc
AirSculpt Technologies Inc. (AIRS) reported a significant surge in revenue for the third quarter of 2023, with a growth of 20.315% to $46.79 million compared to the same period last year. Despite this positive news, the company experienced a loss of $0.03 per share.
In comparison to its sector contemporaries in the Healthcare Facilities sector, AirSculpt has clearly outperformed, as the rest of the sector reported a revenue growth of only 8.55% during the same period. However, it is worth noting that the company saw a decrease in earnings per share (EPS) from $0.03 per share in the previous quarter, and a decline in revenue of -15.996% from $55.70 million.
|
| Per Share |
Current |
| Earnings (TTM) |
-0.15 $ |
| Revenues (TTM) |
3.06 $
|
| Cash Flow (TTM) |
- |
| Cash |
0.14 $
|
| Book Value |
1.35 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-0.15 $
|
| Revenues (TTM) |
3.06 $ |
| Cash Flow (TTM) |
- |
| Cash |
0.14 $
|
| Book Value |
1.35 $ |
| Dividend (TTM) |
0 $ |
|
|
| |
On January 13 2025 the Airsculpt Technologies Inc provided following guidance
nnAirSculpt Technologies Inc. Revises Fiscal Year 2024 Financial Projections Ahead of ICR Conference 2025nn
nMIAMI BEACH, Fla., January 13, 2025n ? AirSculpt Technologies, Inc. (NASDAQ: AIRS), a prominent provider of high-end body contouring procedures, has announced today an updated outlook for its fiscal year 2024. This revision comes as the Company prepares to participate in the upcoming ICR Conference 2025, where it will share insights and updates with stakeholders.
While AirSculpt has outlined its commitment to enhancing its financial strategy and growth trajectory, precise figures and specific details regarding the updated fiscal year 2024 guidance have not been disclosed in this anno...
|
|
|
9.33% 